RSS feed

Publications (original articles or review articles) published in 2023 from OUS - Department of Cardiology B (Div Med)

8 publications found

Andreotti F, Geisler T, Collet JP, Gigante B, Gorog DA, Halvorsen S, Lip GYH, Morais J, Navarese EP, Patrono C, Rocca B, Rubboli A, Sibbing D, Storey RF, Verheugt FWA, Vilahur G (2023)
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
Eur Heart J, 44 (4), 262-279
DOI 10.1093/eurheartj/ehac515, PubMed 36477865

Drexel H, Saely CH, Agewall S (2023)
Fibrates: one more lost paradise in lipid treatment
Eur Heart J Cardiovasc Pharmacother, 9 (2), 121
DOI 10.1093/ehjcvp/pvac072, PubMed 36610735

Forfang E, Larsen KT, Salman RA, Bell SM, Wester P, Berge E, Wyller TB, Rønning OM (2023)
Antithrombotic treatment after intracerebral hemorrhage: Surveys among stroke physicians in Scandinavia and the United Kingdom
Health Sci Rep, 6 (1), e1059
DOI 10.1002/hsr2.1059, PubMed 36698713

Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, De Hert S, de Laval I, Geisler T, Hinterbuchner L, Ibanez B, Lenarczyk R, Mansmann UR, McGreavy P, Mueller C, Muneretto C, Niessner A, Potpara TS, Ristić A, Sade LE, Schirmer H, Schüpke S, Sillesen H, Skulstad H, Torracca L et al. (2023)
[2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)]
G Ital Cardiol (Rome), 24 (1), 1e-102e
DOI 10.1714/3956.39326, PubMed 36645369

Karasik A, Lanzinger S, Chia-Hui Tan E, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nyström T, Niskanen L, Linnemann Jensen M, Hoti F, Klement R, Déruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G et al. (2023)
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes Metab, 49 (2), 101418 (in press)
DOI 10.1016/j.diabet.2022.101418, PubMed 36608816

Lyng CS, Gude E, Hodt A, Knudsen EC (2023)
First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant
Scand Cardiovasc J, 57 (1), 2174269
DOI 10.1080/14017431.2023.2174269, PubMed 36734834

Mehilli J, Halvorsen S (2023)
The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
Eur Heart J, 44 (5), 336-337
DOI 10.1093/eurheartj/ehac703, PubMed 36527277

Neglia D, Liga R, Gimelli A, Podlesnikar T, Cvijić M, Pontone G, Miglioranza MH, Guaricci AI, Seitun S, Clemente A, Sumin A, Vitola J, Saraste A, Paunonen C, Sia CH, Paleev F, Sade LE, Zamorano JL, Maroz-Vadalazhskaya N, Anagnostopoulos C, Macedo F, Knuuti J, Edvardsen T, Cosyns B, Petersen SE et al. (2023)
Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry
Eur Heart J, 44 (2), 142-158
DOI 10.1093/eurheartj/ehac640, PubMed 36452988